E-ISSN 2231-3206 | ISSN 2320-4672
 

Original Research

Online Publishing Date:
06 / 07 / 2022

 


A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021

Nilesh Chavda, Nirav Patel, Jatin V Dhanani, Priti Solanky.


Abstract
Background: The pattern of new drug approval is changing across the world as shown by the study using Center for Drug Evaluation and Research and European Medicines Agency data in US and UK with more drug approval for anti-cancer and immunomodulator drugs. There is a need to generate similar database for developed South East Asian countries too.

Aims and Objectives: This study was conducted for one such country- Singapore for the new drug approval pattern of last 5 years (2017–2021).

Materials and Methods: This was a pharmacoepidemiological study, in which government drug regulatory website data available in public domain was searched. The new drug approval data were classified according to active ingredient, drug approval date, new drug application category, indication of drugs, and World Health Organization Anatomic Thoracic Classification.

Results: In this study, 418 new drug approvals were found in last 5 years in Singapore. From this maximum, drug approvals were given to anti-neoplastic and immunomodulator category drugs. In anti-neoplastic category new drugs approval few examples were Trastuzumab deruxtecan and Tucatinib for breast cancer therapy and Tepotinib and Capmatinib for non-small cell lung cancer therapy.

Conclusion: This study shows that drug development in anti-cancer drug and immunomodulator is significant in Singapore. This trend is quite matching with other country such as US and UK.

Key words: New Drug Approval; Singapore; Health Science Authority


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Nilesh Chavda
Articles by Nirav Patel
Articles by Jatin V Dhanani
Articles by Priti Solanky
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Chavda N, Patel N, Dhanani JV, Solanky P. A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 267-273. doi:10.5455/njppp.2023.13.06289202220062022


Web Style

Chavda N, Patel N, Dhanani JV, Solanky P. A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. https://www.njppp.com/?mno=48773 [Access: March 14, 2024]. doi:10.5455/njppp.2023.13.06289202220062022


AMA (American Medical Association) Style

Chavda N, Patel N, Dhanani JV, Solanky P. A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. Natl J Physiol Pharm Pharmacol. 2023; 13(2): 267-273. doi:10.5455/njppp.2023.13.06289202220062022



Vancouver/ICMJE Style

Chavda N, Patel N, Dhanani JV, Solanky P. A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. Natl J Physiol Pharm Pharmacol. (2023), [cited March 14, 2024]; 13(2): 267-273. doi:10.5455/njppp.2023.13.06289202220062022



Harvard Style

Chavda, N., Patel, . N., Dhanani, . J. V. & Solanky, . P. (2023) A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. Natl J Physiol Pharm Pharmacol, 13 (2), 267-273. doi:10.5455/njppp.2023.13.06289202220062022



Turabian Style

Chavda, Nilesh, Nirav Patel, Jatin V Dhanani, and Priti Solanky. 2023. A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 267-273. doi:10.5455/njppp.2023.13.06289202220062022



Chicago Style

Chavda, Nilesh, Nirav Patel, Jatin V Dhanani, and Priti Solanky. "A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021." National Journal of Physiology, Pharmacy and Pharmacology 13 (2023), 267-273. doi:10.5455/njppp.2023.13.06289202220062022



MLA (The Modern Language Association) Style

Chavda, Nilesh, Nirav Patel, Jatin V Dhanani, and Priti Solanky. "A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021." National Journal of Physiology, Pharmacy and Pharmacology 13.2 (2023), 267-273. Print. doi:10.5455/njppp.2023.13.06289202220062022



APA (American Psychological Association) Style

Chavda, N., Patel, . N., Dhanani, . J. V. & Solanky, . P. (2023) A study of new drug approval pattern of a Southeast Asian developed country from 2017 to 2021. National Journal of Physiology, Pharmacy and Pharmacology, 13 (2), 267-273. doi:10.5455/njppp.2023.13.06289202220062022